Reagent Export Market Intelligence: India's 93 Suppliers Shipping to 109 Countries — TransData Nexus 2026

Q: Who are the top reagent exporters from India?

The top reagent exporters from India are: 1. ADVY CHEMICAL PRIVATE LIMITED — $6.9M (52.7% market share); 2. ARKRAY HEALTHCARE PRIVATE LIMITED — $3.3M (24.8% market share); 3. BEACON DIAGNOSTICS PVT LTD — $679.5K (5.2% market share); 4. MEDSOURCE OZONE BIOMEDICALS PRIVATE LIMITED — $295.5K (2.3% market share); 5. BEACON DIAGNOSTICS PRIVATE LIMITED — $226.5K (1.7% market share). Together they account for 86.7% of India's total reagent export value.

Q: What is the total export value of reagent from India?

The total export value of reagent from India is $13.1M USD, recorded across 5,370 shipment transactions from 93 active exporters to 109 destination countries. The average shipment value is $2.4K.

Q: Which countries import reagent from India?

India exports reagent to 109 countries worldwide. The top importing countries are: GERMANY (13.0% share, $1.7M), JAPAN (8.9% share, $1.2M), UNITED STATES (7.3% share, $956.7K), ITALY (7.0% share, $920.5K), ETHIOPIA (4.7% share, $618.2K). These five markets account for 40.9% of total export value.

Q: What is the HS code for reagent exports from India?

The primary HS code for reagent exports from India is 30029010. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) for tracking and reporting pharmaceutical trade flows.

Q: What is the average price of reagent exports from India?

The average unit price for reagent exports from India is $2701.92 USD per unit, with prices ranging from $0.00 to $98289.84 depending on formulation, packaging, and order volume. The total market is valued at $13.1M across 5,370 shipments.

Q: Which ports handle reagent exports from India?

The primary ports for reagent exports from India are SAHAR AIR CARGO ACC (INBOM4) (42.6% of shipments), SAHAR AIR (26.5% of shipments), Bombay Air (10.4% of shipments), DELHI AIR (5.4% of shipments), DELHI AIR CARGO ACC (INDEL4) (3.6% of shipments). These ports have dedicated pharmaceutical cargo infrastructure ensuring cold-chain and regulatory compliance during transit.

Q: Why is India a leading exporter of reagent?

India is one of the world's leading exporters of reagent due to its large base of 93 WHO-GMP and US FDA approved manufacturers, significantly lower production costs compared to Western markets, well-established API (Active Pharmaceutical Ingredient) supply chains, and strong government support for pharmaceutical exports through the Pharmaceuticals Export Promotion Council (Pharmexcil). India exports reagent to 109 countries, demonstrating 56% global market coverage.

Q: What certifications do Indian reagent exporters need?

Indian reagent exporters typically require WHO-GMP (Good Manufacturing Practice) certification for most regulated markets, US FDA approval for exports to the United States, EU GMP certification for European markets, and country-specific regulatory approvals for markets in Africa, Asia, and Latin America. Additional certifications may include ISO 9001, Schedule M compliance under Indian drug laws, and Free Sale Certificates issued by the Central Drugs Standard Control Organization (CDSCO).

Q: How many buyers import reagent from India?

There are 627 registered buyers importing reagent from India, spread across 109 countries. The repeat buyer rate is 68.6%, indicating strong long-term trade relationships and consistent product quality.

Q: What is the market share of the top reagent supplier from India?

ADVY CHEMICAL PRIVATE LIMITED is the leading reagent exporter from India with a market share of 52.7% and total export value of $6.9M across 2566 shipments. The top 5 suppliers together control 86.7% of total export value.

Suresh Sormare

Reagent

India Pharmaceutical Trade Intelligence

$13.1M93 Suppliers109 CountriesHS 30029010

ExportsIndia → GERMANY13.0%India → JAPAN8.9%

#1 Supplier: ADVY CHEMICAL #1 Buyer: DIASYS DIAGNOSTIC

Reagent Export Analysis | India Pharmaceutical Trade Intelligence | TransData Nexus

How India Exports Reagent to the World

Between 2022 and 2026, India exported $13.1M worth of reagent across 5,370 verified shipments to 109 countries — covering 56% of world markets in the Medical Devices & Diagnostics segment. The largest destination is GERMANY (13.0%). ADVY CHEMICAL PRIVATE LIMITED leads with a 52.7% share. All figures are drawn from Indian Customs (DGFT) shipping bill records spanning four years of trade activity.

Source: Indian Customs (DGFT)·Published March 2026·Updated March 2026·

Reagent export data from India — top exporters, importing countries, pricing and trade statistics compiled by TransData Nexus — Reagent export data snapshot — $13.1M · 93 exporters · 109 countriesTransData Nexus · Indian Customs Data

Top Reagent Exporters from India

93 active exporters · Ranked by export value

View all 93 →

Top Reagent Exporters from India — Ranked by Export Value
#	Supplier Name	Export Value (USD)	Shipments	Countries	Market Share
1	ADVY CHEMICAL PRIVATE LIMITED	$6.9M	2,566	23	52.7%
2	ARKRAY HEALTHCARE PRIVATE LIMITED

Top Countries Importing Reagent from India

109 destination markets · Ranked by import value

All 109 countries →

Top Countries Importing Reagent from India — Ranked by Import Value
#	Country	Import Value (USD)	Market Share
1	GERMANY	$1.7M	13.0%
2	JAPAN	$1.2M	8.9%
3	UNITED STATES	$956.7K	7.3%
4	ITALY	$920.5K	7.0%
5	ETHIOPIA	$618.2K	4.7%
6	CHINA	$597.3K	4.6%
7	NIGERIA	$535.6K	4.1%
8	RUSSIA	$520.9K	4.0%
9	UNITED ARAB EMIRATES	$408.0K	3.1%
10	SPAIN	$368.2K	2.8%

GERMANY is India's largest reagent export destination, absorbing 13.0% of total exports worth $1.7M. The top 5 importing countries — GERMANY, JAPAN, UNITED STATES, ITALY, ETHIOPIA — together account for 40.9% of India's total reagent export value. The remaining 104 destination countries collectively receive the other 59.1%, indicating a well-diversified global distribution network spanning all major continents.

Regulatory Landscape — Reagent

Product-specific regulatory status across FDA, EMA, WHO, and CDSCO · As of March 2026

1FDA & US Market Regulatory Status

The United States Food and Drug Administration (FDA) maintains the Orange Book, a comprehensive resource listing approved drug products and their therapeutic equivalence evaluations. As of January 2026, the Orange Book includes a variety of drug products approved under Abbreviated New Drug Applications (ANDAs). However, specific data regarding the number of approved ANDAs for reagents classified under HS Code 30029010 is not readily available in the public domain. This HS Code pertains to "Ferments, excluding yeasts," which encompasses a range of biological products. Given the broad nature of this category, the regulatory pathway for these products in the U.S. can vary significantly.

For Indian exporters aiming to penetrate the U.S. market, understanding the FDA's regulatory requirements is crucial. The process typically involves submitting an ANDA, demonstrating bioequivalence to a reference listed drug (RLD). The FDA's Orange Book serves as a vital tool in this process, identifying RLDs and providing therapeutic equivalence evaluations. It's important to note that the Orange Book does not mandate drug substitution but offers guidance based on scientific evaluations. Given that 93 active Indian exporters are involved in exporting products under HS Code 30029010, a thorough understanding of the FDA's regulatory framework is essential for successful market entry.

2EU & UK Regulatory Framework

In the European Union (EU) and the United Kingdom (UK), the marketing authorization of pharmaceutical products is governed by the European Medicines Agency (EMA) and the Medicines and Healthcare products Regulatory Agency (MHRA), respectively. Products classified under HS Code 30029010, such as "Ferments, excluding yeasts," are subject to stringent regulatory requirements to ensure their safety, efficacy, and quality. Compliance with Good Manufacturing Practice (GMP) standards is mandatory, encompassing all aspects of production, from raw material sourcing to final product release. Indian exporters targeting these markets must adhere to these regulations, ensuring that their manufacturing processes meet the established GMP criteria.

3WHO Essential Medicines & Global Standards

The World Health Organization (WHO) maintains the Model List of Essential Medicines, which identifies medications considered essential for addressing public health needs. As of the latest edition, specific reagents under HS Code 30029010 are not listed. However, the WHO's Prequalification Programme sets global standards for the quality, safety, and efficacy of medicines, including certain biological products. Compliance with pharmacopoeial standards such as the United States Pharmacopeia (USP), British Pharmacopoeia (BP), European Pharmacopoeia (EP), and Indian Pharmacopoeia (IP) is crucial for international market acceptance. Indian exporters should ensure their products meet these standards to facilitate global distribution.

4India Regulatory Classification

In India, the Central Drugs Standard Control Organization (CDSCO) classifies pharmaceutical products into various schedules under the Drugs and Cosmetics Act. Products under HS Code 30029010, such as "Ferments, excluding yeasts," may fall under different schedules depending on their specific use and composition. The National Pharmaceutical Pricing Authority (NPPA) regulates the pricing of essential medicines through the Drug Price Control Order (DPCO). As of March 2026, there is no specific ceiling price listed for products under this HS Code. For exports, obtaining a No Objection Certificate (NOC) from the Directorate General of Foreign Trade (DGFT) is typically required, ensuring compliance with national regulations.

5Patent & Exclusivity Status

The patent status and market exclusivity of products under HS Code 30029010 vary based on their specific formulations and intended uses. Given the diverse nature of products classified under this code, a detailed patent search is necessary to determine the presence of active patents or exclusivity periods. Generic competition is influenced by these factors, and Indian exporters should conduct thorough due diligence to assess market entry opportunities and potential challenges.

6Recent Industry Developments

In the past 12 months, several developments have impacted the pharmaceutical industry relevant to products under HS Code 30029010:

1. API Price Fluctuations: In June 2025, the Indian Ministry of Chemicals and Fertilizers reported a 5% increase in the prices of certain Active Pharmaceutical Ingredients (APIs) due to supply chain disruptions.

2. Regulatory Approvals: In September 2025, the CDSCO approved a new fermentation-based product for therapeutic use, expanding the scope for products under HS Code 30029010.

3. Policy Changes: In December 2025, the NPPA revised the DPCO, adding new formulations to the list of price-controlled drugs, impacting the pricing strategies for certain pharmaceutical products.

These developments underscore the dynamic nature of the pharmaceutical regulatory landscape, necessitating continuous monitoring by exporters to adapt to changing market conditions and regulatory requirements.

TransData Nexus Research · FDA Orange Book, EMA, WHO Model List, CDSCO/NPPAUpdated Mar 2026

Get Complete Export Intelligence Report

300+ pages · Supplier profiles · Buyer analysis · Price benchmarks · Every shipment record

Free

Supply Chain Risk Assessment — Reagent

API sourcing, concentration risk, storage requirements, and current alerts

HIGH RISK

1API Sourcing & Raw Material Dependency

India's pharmaceutical industry, often referred to as the "pharmacy of the world," heavily relies on China for Key Starting Materials (KSMs) essential in Active Pharmaceutical Ingredient (API) production. Approximately 60–70% of these critical inputs are imported from China, creating a significant dependency. This reliance became evident during the COVID-19 pandemic when disruptions in Chinese manufacturing led to shortages and price hikes for various APIs and KSMs.

To mitigate this vulnerability, the Indian government launched the Production Linked Incentive (PLI) scheme in October 2024, aiming to bolster domestic production of APIs and KSMs. Two greenfield plants were inaugurated under this initiative to manufacture essential molecules like Penicillin G and 6-Aminopenicillanic acid (6-APA), which had not been produced domestically for over two decades. These efforts are projected to reduce India's import dependence on key pharmaceutical ingredients by half.

2Supplier Concentration & Single-Source Risk

Our proprietary trade data from 2022 to 2026 indicates that the top five Indian exporters of "Reagent" account for 86.7% of total exports, with ADVY CHEMICAL PRIVATE LIMITED alone contributing 52.7%. This high supplier concentration poses a significant single-source risk, as any disruption affecting these key players could severely impact the global supply chain.

Access Complete Reagent Trade Intelligence

Shipment-level records, verified supplier contacts, buyer histories, and pricing analytics for all 5,370 transactions across 109 markets.

Request Demo View Pricing

Frequently Asked Questions — Reagent Exports from India

Data-backed answers sourced from Indian Customs shipping bill records

Who are the top reagent exporters from India?

The leading reagent exporters from India are ADVY CHEMICAL PRIVATE LIMITED, ARKRAY HEALTHCARE PRIVATE LIMITED, BEACON DIAGNOSTICS PVT LTD, and 9 others. ADVY CHEMICAL PRIVATE LIMITED leads with 52.7% market share ($6.9M). The top 5 suppliers together control 86.7% of total export value.

What is the total export value of reagent from India?

The total export value of reagent from India is $13.1M, recorded across 5,370 shipments from 93 active exporters to 109 countries. The average shipment value is $2.4K.

Which countries import reagent from India?

India exports reagent to 109 countries. The top importing countries are GERMANY (13.0%), JAPAN (8.9%), UNITED STATES (7.3%), ITALY (7.0%), ETHIOPIA (4.7%), which together account for 40.9% of total export value.

What is the HS code for reagent exports from India?

The primary HS code for reagent exports from India is 30029010. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) to track and report pharmaceutical export flows.

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Reagent

Reagent

How India Exports Reagent to the World

Top Reagent Exporters from India

Top Countries Importing Reagent from India

Quick Facts

Related Medical Devices & Diagnostics

Related Analysis

Need Details?

Regulatory Landscape — Reagent

1FDA & US Market Regulatory Status

2EU & UK Regulatory Framework

3WHO Essential Medicines & Global Standards

4India Regulatory Classification

5Patent & Exclusivity Status

6Recent Industry Developments

Supply Chain Risk Assessment — Reagent

1API Sourcing & Raw Material Dependency

2Supplier Concentration & Single-Source Risk

Access Complete Reagent Trade Intelligence

Frequently Asked Questions — Reagent Exports from India

Who are the top reagent exporters from India?

What is the total export value of reagent from India?

Which countries import reagent from India?

What is the HS code for reagent exports from India?

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

3Geopolitical & Shipping Disruptions

4Risk Mitigation Recommendations

What is the average price of reagent exports from India?

Which ports handle reagent exports from India?

Why is India a leading exporter of reagent?

What certifications do Indian reagent exporters need?

How many buyers import reagent from India?

What is the market share of the top reagent exporter from India?

Analysis Methodology